Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-016041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-03 | 2023-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +54.9K | 569.4K | +11% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $45.65 | -16.1K | 599.2K | -3% | -$736.8K |
| D | 2023-03-03 | 2023-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +83.5K | 83.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | A | A | 46,200 | $0.00 | 615,606 | D | — | — | (F2) Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. |
| 2 | Common | Common Stock | 2023-03-01 | F | D | 16,140 | $45.65 | 599,176 | D | — | — | (F3) Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. (F4) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. (F5) Reflects transfer of directly owned shares of common stock from the Reporting Person to a trust indirectly held by the Reporting Person that have taken place since the most recent prior report on Form 4. |
| 3 | Common | Common Stock | 2023-03-01 | A | A | 8,716 | $0.00 | 569,406 | D | — | — | (F1) Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-03-01 | A | A | 83,500 | $0.00 | 83,500 | D | $45.65 · — to 2033-03-01 | 83,500 Common Stock | (F6) On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. |